Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $484.43 | 8 | 81.2% |
| Consulting Fee | $112.50 | 1 | 18.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $156.00 | 2 | $0 (2022) |
| SI-BONE, Inc. | $131.59 | 1 | $0 (2017) |
| ZOLL Medical Corporation | $112.50 | 1 | $0 (2021) |
| Pernix Therapeutics Holdings, Inc. | $47.31 | 1 | $0 (2017) |
| Averitas Pharma Inc. | $46.00 | 1 | $0 (2023) |
| GRT US Holding, Inc. | $45.00 | 1 | $0 (2022) |
| Arbor Pharmaceuticals, Inc. | $34.41 | 1 | $0 (2017) |
| Allergan Inc. | $24.12 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $46.00 | 1 | Averitas Pharma Inc. ($46.00) |
| 2022 | $99.41 | 2 | Collegium Pharmaceutical, Inc. ($54.41) |
| 2021 | $112.50 | 1 | ZOLL Medical Corporation ($112.50) |
| 2017 | $339.02 | 5 | SI-BONE, Inc. ($131.59) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $46.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/07/2022 | Collegium Pharmaceutical, Inc. | BELBUCA (Drug), Xtampza | Food and Beverage | Cash or cash equivalent | $54.41 | General |
| Category: Opioid Analgesic | ||||||
| 09/06/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Pain Management | ||||||
| 01/27/2021 | ZOLL Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $112.50 | General |
| Category: DEFIBRILLATOR | ||||||
| 08/23/2017 | Arbor Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $34.41 | General |
| Category: Sleep | ||||||
| 06/24/2017 | Collegium Pharmaceutical, Inc. | Xtampza ER (Drug) | Food and Beverage | Cash or cash equivalent | $101.59 | General |
| Category: Opioid Analgesic | ||||||
| 06/24/2017 | Pernix Therapeutics Holdings, Inc. | ZOHYDRO ER (Drug) | Food and Beverage | In-kind items and services | $47.31 | General |
| Category: PAIN | ||||||
| 05/19/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/02/2017 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | Cash or cash equivalent | $131.59 | General |
| Category: sacroiliac joint dysfunction | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 69 | 73 | $12,205 | $3,794 |
| 2020 | 2 | 41 | 43 | $7,139 | $2,363 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2021 | 25 | 25 | $6,200 | $1,719 | 27.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 33 | 37 | $3,959 | $1,367 | 34.5% |
| 95909 | Nerve transmission studies, 5-6 studies | Facility | 2021 | 11 | 11 | $2,046 | $708.29 | 34.6% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2020 | 18 | 18 | $4,464 | $1,522 | 34.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2020 | 23 | 25 | $2,675 | $841.49 | 31.5% |
About Dr. Stephen Kishner, MD
Dr. Stephen Kishner, MD is a Physical Medicine & Rehabilitation healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285657114.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Kishner, MD has received a total of $596.93 in payments from pharmaceutical and medical device companies, with $46.00 received in 2023. These payments were reported across 9 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($484.43).
As a Medicare-enrolled provider, Kishner has provided services to 110 Medicare beneficiaries, totaling 116 services with total Medicare billing of $6,157. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location New Orleans, LA
- Active Since 07/25/2006
- Last Updated 10/29/2008
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1285657114
Products in Payments
- iFuse Implant (Device) $131.59
- Xtampza ER (Drug) $101.59
- BELBUCA (Drug) $54.41
- ZOHYDRO ER (Drug) $47.31
- QUTENZA (Drug) $46.00
- Qutenza (Drug) $45.00
- Horizant (Drug) $34.41
- BOTOX THERAPEUTIC (Biological) $24.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in New Orleans
Hazem Eissa, Md, MD
Physical Medicine & Rehabilitation — Payments: $76,569
Dr. Joshua Kaufman, Md, MD
Physical Medicine & Rehabilitation — Payments: $8,506
Casey Murphy, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $5,402
Dr. Jonathan Finney, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,560
Jeffrey Watkins, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,222
Dr. Ariean Loo-Hernandez, Do, DO
Physical Medicine & Rehabilitation — Payments: $771.35